In glioblastoma, miR-139 inhibits Notch1/Hes1, thereby suppressing the activation of the Wnt/β-catenin pathway, thus inhibiting glioma stem cell stemness and tumorigenesis (116). This evidence concerns the gene HES1 and glioma.